1. Home
  2. COGT vs RUSHB Comparison

COGT vs RUSHB Comparison

Compare COGT & RUSHB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cogent Biosciences Inc.

COGT

Cogent Biosciences Inc.

HOLD

Current Price

$39.57

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Logo Rush Enterprises Inc. Class B

RUSHB

Rush Enterprises Inc. Class B

HOLD

Current Price

$78.99

Market Cap

5.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
COGT
RUSHB
Founded
2014
1965
Country
United States
United States
Employees
N/A
7355
Industry
Biotechnology: Pharmaceutical Preparations
Retail-Auto Dealers and Gas Stations
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
5.9B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
COGT
RUSHB
Price
$39.57
$78.99
Analyst Decision
Strong Buy
Analyst Count
15
0
Target Price
$36.21
N/A
AVG Volume (30 Days)
2.3M
94.9K
Earning Date
05-06-2026
04-28-2026
Dividend Yield
N/A
1.04%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,871,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1,733.58
$5.44
P/E Ratio
N/A
$16.53
Revenue Growth
N/A
N/A
52 Week Low
$10.38
$47.71
52 Week High
$43.73
$79.13

Technical Indicators

Market Signals
Indicator
COGT
RUSHB
Relative Strength Index (RSI) 56.60 67.99
Support Level $36.09 $73.26
Resistance Level $40.67 N/A
Average True Range (ATR) 1.73 2.36
MACD -0.05 0.07
Stochastic Oscillator 65.50 85.97

Price Performance

Historical Comparison
COGT
RUSHB

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

About RUSHB Rush Enterprises Inc. Class B

Rush Enterprises Inc is a full-service, integrated retailer of commercial vehicles and related services. The company operates in a single segment; Truck Segment includes the operation of a network of commercial vehicle dealerships under the name Rush Truck Centers. It sells commercial vehicles manufactured by Peterbilt, International, Hino, Ford, Isuzu, IC Bus, and Blue Bird and also provides one-stop service for the needs of commercial vehicle customers, including retail sales of new and used commercial vehicles, aftermarket parts sales, service and repair facilities, financing, leasing and rental, and insurance products. The company's business is concentrated in the United States and Ontario, Canada commercial vehicle markets and related aftermarkets.

Share on Social Networks: